11.08.12
BioClinica
3Q Revenues: $24.9 million (+16%)
3Q Earnings: $542,000 (+51%)
YTD Revenues: $70.7 million (+15%)
YTD Earnings: $2.6 million (+57%)
Comments: Service revenues increased 16% to a record $19.2 million. Current backlog was $114.1 million, up 4% in the quarter. Mark L. Weinstein, president and chief executive officer of BioClinica said, “We are extremely pleased with our third quarter operating results, which included strong growth in service revenue and non-GAAP operating income and margin resulting from increased demand for both our eClinical and medical imaging offerings.”
3Q Revenues: $24.9 million (+16%)
3Q Earnings: $542,000 (+51%)
YTD Revenues: $70.7 million (+15%)
YTD Earnings: $2.6 million (+57%)
Comments: Service revenues increased 16% to a record $19.2 million. Current backlog was $114.1 million, up 4% in the quarter. Mark L. Weinstein, president and chief executive officer of BioClinica said, “We are extremely pleased with our third quarter operating results, which included strong growth in service revenue and non-GAAP operating income and margin resulting from increased demand for both our eClinical and medical imaging offerings.”